Company Overview of Cibus Global, Ltd.
Cibus Global, Ltd. develops precision gene editing systems for agricultural, industrial, and human health markets worldwide. It focuses on the development of industrial biotechnology, agriculture, and human health and wellness solutions by using Rapid Trait Development System (RTDS), a precision gene editing technology that is used to develop new and beneficial characteristics by modifying cell function. The company, through its subsidiary, offers Squalane, an oil compound that is used in cosmetics, pharmaceuticals, and specialty lubricants; and Ergosterol, a natural sterol that is found in yeast and fungal species. Its RTDS technology is used in various applications, including the optimizat...
6455 Nancy Ridge Drive
San Diego, CA 92121
Founded in 2001
Key Executives for Cibus Global, Ltd.
Chief Executive Officer and President
Senior Vice President, Chief Executive Officer of Nucelis and President of Nucelis
Senior Vice President of Research & Development
Head of the Cell Biology Department
Vice President of International Development
Compensation as of Fiscal Year 2014.
Cibus Global, Ltd. Key Developments
Cibus and Rotam Announce Launch of its First Non-Transgenic Commercial Product
Nov 19 14
Cibus Global and Rotam have announced the launch of non-transgenic SU Canola(TM) (Sulfonylurea Tolerant) in the United States. Rotam has developed two new effective weed control solutions specifically designed for use on SU Canola(TM). SU Canola offers farmers a new alternative for weed control in canola that will provide sound stewardship options to deal with the management of glyphosate weed resistance. SU Canola is an optimal fit for rotation with glyphosate tolerant soybeans reducing weed pressure caused by volunteer glyphosate tolerant canola in soybean fields. Farmers can anticipate a product that has been developed to include exceptional broadleaf weed control, excellent crop safety, in an economical and easy-to-use package. Additionally, many participants in the canola industry including processors, farmers, and end use food consumers, will benefit from SU Canola as the oil and meal derived from this canola will address the growing demand for non-transgenic food ingredients. This initiative combines years of Cibus' cutting-edge laboratory research with Rotam's strong manufacturing and production capabilities in bringing two sulfonylurea herbicide products exclusively registered for SU Canola: Draft(TM), designed for Midwest applications, and Cleat(TM), registered for use in California. "Rotam is thrilled to join Cibus and provide a new system featuring its herbicide solutions for canola farmers," said Steve Stansell, Marketing Manager, Rotam North America.
Cibus Global Announces Executive Changes
Jul 8 14
Keith Walker, Ph.D., who has led Cibus Global since the company was founded in 2001, has announced his retirement. Rapid Trait Development System developer, and company's Sr. VP of Research and Development Peter Beetham has been tapped to take the top position at the precision gene editing firm. Walker has been named to the Cibus Board of Directors. Dr. Beetham has led the development of the company's core technologies in gene editing that have driven the company's expansion to more than 100 employees with over 70 scientists focusing on advancing company's patented and gene editing technologies. Greg Gocal, Ph.D., the current Vice President of Research at the company, also a member of the founding group has been promoted to Senior Vice President of Research and Development to oversee all research activities at the company. Dr. Gocal, prior to joining the company held research positions and headed the molecular biology group at Valigen.
Cibus Global Appoints Keith Walker as CEO and President
Sep 16 13
Cibus Global announced that Keith Walker, Ph.D., has been appointed as CEO and President. Dr. Walker has held the position of President since the company was founded in 2001. Prior to Cibus, Dr. Walker held a variety of management positions at the Mycogen Corporation, ranging from business development, biotechnology research management and technology in-and-out-licensing.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 16, 2014